BIZ NEWS: Why Biogen's Alzheimer's Drug Failure May Have a Silver Lining - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Thursday, 28 March 2019

BIZ NEWS: Why Biogen's Alzheimer's Drug Failure May Have a Silver Lining


Why Biogen's Alzheimer's Drug Failure May Have a Silver Lining



The Swiss pharmaceutical company halted its trial of aducanumab because it wasn't helping patients. But it could still help researchers.

via FOX BUSINESS NEWS https://ift.tt/2FHjt4x

No comments:

Post a Comment

Post Top Ad